You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九洲藥業(603456.SH)擬定增募資不超10億元 投資研發中心項目等
格隆匯 09-07 20:44

格隆匯9月7日丨九洲藥業(603456.SH)發佈2020年非公開發行A股股票預案,本次非公開發行A股的股票數量不超過4500萬股(含4500萬股),不超過本次非公開發行A股前公司總股本的30%,且募集資金總額不超過10億元(含10億元),最終非公開發行A股股票數量計算至個位數(計算結果向下取整),並以中國證監會的核準文件為準。

本次非公開發行A股股票的對象為不超過35名特定投資者,包括符合中國證監會規定條件的證券投資基金管理公司、證券公司、信託公司、財務公司、保險機構投資者、合格境外機構投資者以及其他符合相關法律、法規規定條件的法人、自然人或其他機構投資者。

本次非公開發行A股股票募集資金總額不超過10億元(含本數),募集資金扣除相關發行費用後將用於投資瑞博(蘇州)製藥有限公司研發中心項目、瑞博(杭州)醫藥科技有限公司研發中心項目、浙江四維醫藥科技有限公司CDMO製劑項目、浙江四維醫藥科技有限公司百億片製劑工程項目(一期)及補充流動資金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account